A self-administered, artificial intelligence (AI) platform for cognitive assessment in multiple sclerosis (MS).

Journal: BMC neurology

Published Date: May 18, 2020

Abstract

BACKGROUND: Cognitive impairment is common in patients with multiple sclerosis (MS). Accurate and repeatable measures of cognition have the potential to be used as markers of disease activity.

Authors

Seyed-Mahdi Khaligh-Razavi

Cognetivity Ltd, London, UK. seyed@cognetivity.com.
Maryam Sadeghi
Mahdiyeh Khanbagi

Department of Brain and Cognitive Sciences, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
Chris Kalafatis

Cognetivity Ltd, London, UK.
Seyed Massood Nabavi

Department of Brain and Cognitive Sciences, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.

Keywords

Adolescent Adult Artificial Intelligence Case-Control Studies Cognitive Dysfunction Female Humans Learning Male Middle Aged Multiple Sclerosis Neuropsychological Tests Reproducibility of Results Young Adult

External Resources

View on PubMed Access via DOI PubMed (32423386)

A self-administered, artificial intelligence (AI) platform for cognitive assessment in multiple sclerosis (MS).

Abstract

Authors

Keywords

External Resources

Popular Topics

Recent Journals